Zobrazeno 1 - 6
of 6
pro vyhledávání: '"DZ L'Heureux"'
Autor:
David A. Mankoff, PJ Jolles, Lalitha K. Shankar, Michael O. Idowu, Fenghai Duan, DZ L'Heureux, Harry D. Bear, L Kostakoglu, Karen A. Kurdziel
Publikováno v:
Cancer Research. 71:OT2-05
Background Neoadjuvant chemotherapy (NAC) prior to surgery provides enhanced options for locoregional management and has become an integral component of primary breast cancer management. Initial tumor response in patients receiving NAC is generally d
Autor:
Keith D. Paulsen, DZ L'Heureux, Brian W. Pogue, Zheng Zhang, Nola M. Hylton, Albert E. Cerussi, Steven J. Isakoff, Phillip E. Kaufman, Arjun G. Yodh, Rita S. Mehta, BJ Tromberg, David A. Boas, David A. Mankoff, John Butler, Philip M. Carpenter
Publikováno v:
Cancer Research. 71:OT2-05
Background Imaging technologies monitoring and predicting breast cancer response to neoadjuvant chemotherapy (NAC) are of increasing interest. The utility of conventional imaging approaches varies and identifies the need for alternate functional imag
Autor:
I Bedrosian, DZ L'Heureux, Y-Ct Shih, Christopher Comstock, VJ Suman, Twf Yen, Constantine Gatsonis, K Yao, E Kim, R Birdwell, Gillian M. Newstead
Publikováno v:
Cancer Research. 71:OT2-05
Background Surgical planning and local-regional treatment of breast cancer relies on accurate assessment of disease extent including the primary tumor size and the presence/absence of multiple tumor foci. As a staging modality for breast cancer, MRI
Publikováno v:
Cancer Research. 71:OT2-03
Background Functional MRI techniques may be utilized for characterizing breast tumors and measuring response to neoadjuvant chemotherapy (NAC). Dynamic contrast enhanced (DCE) MRI is the most common functional breast MRI technique. Fitting DCE MRI da
ACRIN 6688 phase II study of fluorine-18 3′-deoxy-3′ fluorothymidine (FLT) in invasive breast cancer
Autor:
DZ L'Heureux, David A. Mankoff, Lalitha K. Shankar, Michael O. Idowu, Harry D. Bear, Lale Kostakoglu, Karen A. Kurdziel, Fenghai Duan, Paul R. Jolles
Publikováno v:
Journal of Clinical Oncology. 29:TPS125-TPS125
TPS125 Background: Neoadjuvant chemotherapy (NAC) prior to surgery provides enhanced options for locoregional management and has become an integral component of primary breast cancer management. Initial tumor response in patients receiving NAC is gen
Autor:
John Butler, Donna Hartfeil, Nola M. Hylton, Steven J. Isakoff, Rita S. Mehta, Albert E. Cerussi, DZ L'Heureux, Bruce J. Tromberg, Keith D. Paulsen, Zheng Zhang, Brian W. Pogue, Peter A. Kaufman, Philip M. Carpenter, Arjun G. Yodh, David A. Mankoff, David A. Boas
Publikováno v:
Journal of Clinical Oncology. 29:TPS249-TPS249
TPS249 Background: Imaging technologies monitoring and predicting breast cancer response to neoadjuvant chemotherapy (NAC) are of increasing interest. The utility of conventional imaging approaches...